Long a maker of low-end generic drugs, China is now home to biotech firms that are innovating fast, The Wall Street Journal says.
The Wall Street Journal reports on China’s ambitions in the race for the next big weight-loss drug. It describes a changing pharmaceutical industry: a country long known for making low-end generic drugs is now home to rapidly innovating biotech firms.
67.7K
1 post, first seen 2d ago
Long a maker of low-end generic drugs, China is now home to biotech firms that are innovating fast, The Wall Street Journal says.
The Wall Street Journal reports on China’s ambitions in the race for the next big weight-loss drug. It describes a changing pharmaceutical industry: a country long known for making low-end generic drugs is now home to rapidly innovating biotech firms.
The Wall Street Journal@WSJLong a maker of low-end generic drugs, the country is now home to biotech firms that are innovating fast. https://on.wsj.com/4yoblh0
Not enough discussion yet.
No sentiment analysis available yet.
Not enough discussion yet.
No sentiment analysis available yet.
—
Not ranked yet
—
Not ranked yet
The Wall Street Journal@WSJLong a maker of low-end generic drugs, the country is now home to biotech firms that are innovating fast. https://on.wsj.com/4yoblh0